Cell Reports (Nov 2023)

Transgenic mouse models support a protective role of type I IFN response in SARS-CoV-2 infection-related lung immunopathology and neuroinvasion

  • Nishant Ranjan Chauhan,
  • Soumya Kundu,
  • Ramyasingh Bal,
  • Diya Chattopadhyay,
  • Rinku Sahu,
  • Subhash Mehto,
  • Rina Yadav,
  • Sivaram Krishna,
  • Kautilya Kumar Jena,
  • Sameekshya Satapathy,
  • Anusha Pv,
  • Krushna C. Murmu,
  • Bharati Singh,
  • Srinivas Patnaik,
  • Sarita Jena,
  • Krishnan H. Harshan,
  • Gulam Hussain Syed,
  • Mohammed M. Idris,
  • Punit Prasad,
  • Santosh Chauhan

Journal volume & issue
Vol. 42, no. 11
p. 113275

Abstract

Read online

Summary: Type I interferon (IFN-I) response is the first line of host defense against invading viruses. In the absence of definite mouse models, the role of IFN-I in SARS-CoV-2 infection remains perplexing. Here, we develop two mouse models, one with constitutively high IFN-I response (hACE2; Irgm1−/−) and the other with dampened IFN-I response (hACE2; Ifnar1−/−), to comprehend the role of IFN-I response. We report that hACE2; Irgm1−/− mice are resistant to lethal SARS-CoV-2 infection. In contrast, a severe SARS-CoV-2 infection along with immune cell infiltration, cytokine storm, and enhanced pathology is observed in the lungs and brain of hACE2; Ifnar1−/− mice. The hACE2; Irgm1−/−Ifnar1−/− double-knockout mice display loss of the protective phenotype observed in hACE2; Irgm1−/− mice, suggesting that heightened IFN-I response accounts for the observed immunity. Taking the results together, we demonstrate that IFN-I protects from lethal SARS-CoV-2 infection, and Irgm1 (IRGM) could be an excellent therapeutic target against SARS-CoV-2.

Keywords